800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredNo results found!
Opioid Use Disorder Treatment for the Fresh Meadows Area
Fresh Meadows, along with neighboring Hillcrest and Kew Gardens Hills, is a largely residential part of central Queens, and for many people here the most practical treatment is care that fits around a job and a home routine. That can mean buprenorphine or naltrexone through a doctor’s office or telehealth, filled at a local pharmacy. Or it may mean methadone through an opioid treatment program when that is the better fit.
The listings below show programs serving the area, and this page explains how the options differ.
Medications and Settings: Clinic, Office, and Pharmacy
Three medications are used for the treatment of opioid use disorder.
Methadone, a full opioid agonist, steadies withdrawal and cravings and, for opioid use disorder, is dispensed only at a federally certified opioid treatment program, not a pharmacy.
Naltrexone, including the monthly Vivitrol injection, blocks opioid effects and is prescribed by a clinician after a set opioid-free period.
Buprenorphine, which includes Suboxone and the monthly Sublocade injection, is a partial agonist that any clinician with a standard DEA registration can prescribe in an office for you to fill at a pharmacy.
Because the setting often decides the daily rhythm of treatment, comparing methadone and Suboxone and understanding what an opioid treatment program involves can help you decide with a clinician.
Taking the First Step
Your first visit is an assessment. A clinician confirms an opioid use disorder, reviews your history, and talks through which medication and setting suit you. Because fentanyl lingers in the body, starting buprenorphine too early can cause sudden, severe withdrawal (precipitated withdrawal), so a clinician times the first dose with you.
For a broader look at the options, see how opioid use disorder treatment works. Nothing here is a diagnosis or a recommendation of a specific treatment.
Take-Homes, Telehealth, and Long-Term Treatment
Federal changes finalized in 2024 expanded take-home methadone to as much as a 28-day supply for patients who are stable. New laws also allowed treatment to begin by telehealth and removed older admission barriers such as the former one-year requirement. Your program decides take-home eligibility based on your stability.
As of August 2026, buprenorphine can be started by telehealth, including by phone in many cases, without a prior in-person visit. For a those with transportation challenges, these flexibilities can make long-term treatment easier to sustain.
These rules run through the end of 2026, so confirm the current options with a provider.
Coverage and Cost
New York Medicaid covers all three medications for opioid use disorder; buprenorphine and naltrexone fill through the state’s NYRx pharmacy benefit, and methadone is provided at an opioid treatment program. Most private plans in New York cover buprenorphine and naltrexone, while methadone coverage in commercial plans varies, so check with the program.
If you are uninsured, many OASAS-certified programs use sliding-scale fees, and the state’s Buprenorphine Assistance Program can help cover the medication. Confirm what a program accepts before your first visit.
Overdose in Queens and the Fresh Meadows area
Queens carried the lowest overdose death rate of the five boroughs in 2024, with deaths across the borough falling from 465 in 2023 to 319, a rate of 17.2 per 100,000 residents, per the NYC Department of Health and Mental Hygiene. Fresh Meadows is a small area, and its own count held at 13 deaths in both 2023 and 2024, numbers small enough that a single year should not be read as a trend.
Citywide, deaths fell 28 percent, with fentanyl present in 73 percent of them. These figures reflect real losses, and the same period widened access to medication that treats opioid use disorder and reduces overdose risk.
Treatment, Work, and Privacy
A common worry in a residential, working neighborhood is whether treatment will show up at work or in daily life. Federal privacy protections cover substance use disorder treatment records, and office-based buprenorphine or telehealth can fit around a work schedule without daily clinic visits.
If your questions are about employment and confidentiality, treatment and the workplace covers what employers can and cannot ask. Family members are often the ones helping someone take a first step, and guidance for families explains how to help while respecting a person’s privacy.
Naloxone and Good Samaritan Guidance
Naloxone, sold as Narcan, reverses an opioid overdose, and every New York pharmacy can provide it without a prescription under a statewide standing order. Additionally, state programs lower the cost, and community groups give it out free. A return to use is a manageable part of recovery, and keeping naloxone on hand is a straightforward safeguard for the whole household.
New York’s 911 Good Samaritan Law protects you from arrest for drug possession when you call for help during an overdose. Don’t hesitate. Call 911.
Questions From the Fresh Meadows Area
Can I be treated without going to a clinic every day?
Often, yes. Buprenorphine and naltrexone are managed through an office or telehealth, not a daily clinic, and even methadone can move to take-home dosing once you are stable in treatment.
Will my employer find out?
Substance use disorder treatment records carry federal privacy protections, and office-based or telehealth care can fit around work. Ask a provider how your information is handled if this is a concern.
Is long-term medication a sign treatment is not working?
No. Many people do best staying on medication for years, and leading medical organizations treat that as effective, ongoing care rather than an unfinished step.
Review and Disclosures
Last reviewed August 2026.
Sources:
- NYC Department of Health and Mental Hygiene, Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2024, Epi Data Brief No. 150 (2025)
- New York State Office of Addiction Services and Supports, Opioid Use Disorder
- New York State Department of Health, Standing Order for Naloxone in Pharmacies
- U.S. Food and Drug Administration, Information about Medications for Opioid Use Disorder (MOUD)
Methadone Centers is an informational directory, not a treatment provider or medical practice. The information on this page is educational and is not medical advice or a diagnosis. Make treatment decisions with a licensed clinician.
By calling a helpline on this site, you agree to our terms of use. Calls to a number on a specific treatment center listing are routed to that center; calls to a general helpline may be forwarded to SAMHSA or to a verified treatment provider. Methadone Centers receives no commission or fee based on which provider a caller chooses, and there is no obligation to enter treatment.
Last Updated: August 27, 2026